The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia

Clinical trial NCT06270108 · UNKNOWN

Trial details

NCT number: NCT06270108
Sponsor: King's College London
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Treatment-resistant Schizophrenia Treatment-responsive Schizophrenia Healthy Controls

Start date: 2022-11-14
Primary completion: 2024-12-31
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.